SE9903236D0 - Method to obtain microparticles - Google Patents

Method to obtain microparticles

Info

Publication number
SE9903236D0
SE9903236D0 SE9903236A SE9903236A SE9903236D0 SE 9903236 D0 SE9903236 D0 SE 9903236D0 SE 9903236 A SE9903236 A SE 9903236A SE 9903236 A SE9903236 A SE 9903236A SE 9903236 D0 SE9903236 D0 SE 9903236D0
Authority
SE
Sweden
Prior art keywords
polymer
active substance
obtaining microparticles
atomized
emulsified
Prior art date
Application number
SE9903236A
Other languages
English (en)
Swedish (sv)
Inventor
Brita Sjoeblom
Original Assignee
Astra Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astra Ab filed Critical Astra Ab
Priority to SE9903236A priority Critical patent/SE9903236D0/xx
Publication of SE9903236D0 publication Critical patent/SE9903236D0/xx
Priority to ES00963188T priority patent/ES2200933T3/es
Priority to DK00963188T priority patent/DK1214058T3/da
Priority to DE60003933T priority patent/DE60003933T2/de
Priority to CA002382005A priority patent/CA2382005A1/en
Priority to AT00963188T priority patent/ATE245022T1/de
Priority to PCT/SE2000/001682 priority patent/WO2001019345A1/en
Priority to NZ517525A priority patent/NZ517525A/en
Priority to JP2001522980A priority patent/JP2003509361A/ja
Priority to AU74637/00A priority patent/AU775458B2/en
Priority to US09/674,043 priority patent/US6753014B1/en
Priority to EP00963188A priority patent/EP1214058B1/de
Priority to US10/851,702 priority patent/US20040219222A1/en
Priority to US11/339,206 priority patent/US20060159756A1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1682—Processes
    • A61K9/1694—Processes resulting in granules or microspheres of the matrix type containing more than 5% of excipient

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Manufacturing Of Micro-Capsules (AREA)
  • Drying Of Solid Materials (AREA)
  • Vaporization, Distillation, Condensation, Sublimation, And Cold Traps (AREA)
  • Physical Or Chemical Processes And Apparatus (AREA)
SE9903236A 1999-09-10 1999-09-10 Method to obtain microparticles SE9903236D0 (sv)

Priority Applications (14)

Application Number Priority Date Filing Date Title
SE9903236A SE9903236D0 (sv) 1999-09-10 1999-09-10 Method to obtain microparticles
EP00963188A EP1214058B1 (de) 1999-09-10 2000-09-01 Verfahren zur herstellung von mikropartikeln
PCT/SE2000/001682 WO2001019345A1 (en) 1999-09-10 2000-09-01 Method to obtain microparticles
DK00963188T DK1214058T3 (da) 1999-09-10 2000-09-01 Fremgangsmåde til opnåelse af mikorpartikler
DE60003933T DE60003933T2 (de) 1999-09-10 2000-09-01 Verfahren zur herstellung von mikropartikeln
CA002382005A CA2382005A1 (en) 1999-09-10 2000-09-01 Method to obtain microparticles
AT00963188T ATE245022T1 (de) 1999-09-10 2000-09-01 Verfahren zur herstellung von mikropartikeln
ES00963188T ES2200933T3 (es) 1999-09-10 2000-09-01 Metodo para obtener microparticulas.
NZ517525A NZ517525A (en) 1999-09-10 2000-09-01 Method to obtain microparticles
JP2001522980A JP2003509361A (ja) 1999-09-10 2000-09-01 微細粒子を得る方法
AU74637/00A AU775458B2 (en) 1999-09-10 2000-09-01 Method to obtain microparticles
US09/674,043 US6753014B1 (en) 1999-09-10 2000-09-01 Method to obtain microparticles
US10/851,702 US20040219222A1 (en) 1999-09-10 2004-05-20 Method to obtain microparticles
US11/339,206 US20060159756A1 (en) 1999-09-10 2006-01-25 Method to obtain microparticles containing an H+,K+-ATP-ASE inhibitor

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE9903236A SE9903236D0 (sv) 1999-09-10 1999-09-10 Method to obtain microparticles

Publications (1)

Publication Number Publication Date
SE9903236D0 true SE9903236D0 (sv) 1999-09-10

Family

ID=20416948

Family Applications (1)

Application Number Title Priority Date Filing Date
SE9903236A SE9903236D0 (sv) 1999-09-10 1999-09-10 Method to obtain microparticles

Country Status (12)

Country Link
US (2) US6753014B1 (de)
EP (1) EP1214058B1 (de)
JP (1) JP2003509361A (de)
AT (1) ATE245022T1 (de)
AU (1) AU775458B2 (de)
CA (1) CA2382005A1 (de)
DE (1) DE60003933T2 (de)
DK (1) DK1214058T3 (de)
ES (1) ES2200933T3 (de)
NZ (1) NZ517525A (de)
SE (1) SE9903236D0 (de)
WO (1) WO2001019345A1 (de)

Families Citing this family (49)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1074923C (zh) 1993-11-19 2001-11-21 詹森药业有限公司 微囊密封的3-哌啶基取代的1,2-苯并异唑类和1,2-苯并异噻唑类
SE0100823D0 (sv) * 2001-03-09 2001-03-09 Astrazeneca Ab Method I to obtain microparticles
US20060159756A1 (en) * 1999-09-10 2006-07-20 Brita Sjoblom Method to obtain microparticles containing an H+,K+-ATP-ASE inhibitor
US6284283B1 (en) * 1999-10-21 2001-09-04 Alkermes Controlled Therapeutics, Inc. Method of producing sub-micron particles of biologically active agents and uses thereof
US10179130B2 (en) 1999-10-29 2019-01-15 Purdue Pharma L.P. Controlled release hydrocodone formulations
KR100889069B1 (ko) 1999-10-29 2009-03-17 유로-셀티크 소시에떼 아노뉨 서방성 하이드로코돈 제형
GB0004827D0 (en) * 2000-02-29 2000-04-19 Quadrant Holdings Cambridge Compositions
DE10026698A1 (de) 2000-05-30 2001-12-06 Basf Ag Selbstemulgierende Wirkstoffformulierung und Verwendung dieser Formulierung
US6824822B2 (en) 2001-08-31 2004-11-30 Alkermes Controlled Therapeutics Inc. Ii Residual solvent extraction method and microparticles produced thereby
AU2738302A (en) 2000-10-30 2002-05-15 Euro Celtique Sa Controlled release hydrocodone formulations
SE0100822D0 (sv) * 2001-03-09 2001-03-09 Astrazeneca Ab Method II to obtain microparticles
AU2002366616A1 (en) * 2001-12-10 2003-06-23 Hte Aktiengesellschaft The High Throughput Experimentation Company Production and shaping of shaped bodies by means of low-temperature cooling and drying processes
GB2399084B (en) 2002-07-30 2007-01-31 Univ Liverpool Porous beads and method of production thereof
CN100366249C (zh) * 2002-09-29 2008-02-06 天津帝士力投资控股集团有限公司 一种替莫唑胺控释给药系统
US8377952B2 (en) 2003-08-28 2013-02-19 Abbott Laboratories Solid pharmaceutical dosage formulation
US8025899B2 (en) 2003-08-28 2011-09-27 Abbott Laboratories Solid pharmaceutical dosage form
RU2006126051A (ru) * 2003-12-19 2008-01-27 Альк-Абелло А/С (Dk) Способы получения партии активного фармацевтического ингредиента, контейнер, содержащий криогранулы аллергенного продукта, и криогранула аллергенного продукта
GB0401950D0 (en) * 2004-01-28 2004-03-03 Unilever Plc Porous bodies and method of production thereof
US7544720B2 (en) 2004-01-28 2009-06-09 Conopco, Inc. Porous polymeric materials and method of production thereof
GB0401947D0 (en) * 2004-01-28 2004-03-03 Unilever Plc Porous bodies and method of production thereof
US8617613B2 (en) 2004-04-15 2013-12-31 Alkermes Pharma Ireland Limited Polymer-based sustained release device
US7456254B2 (en) 2004-04-15 2008-11-25 Alkermes, Inc. Polymer-based sustained release device
ITRM20040539A1 (it) * 2004-11-02 2005-02-02 Mavi Sud S R L Preparati a base di chitina o suoi derivati per uso cosmetico o medico.
US11246913B2 (en) 2005-02-03 2022-02-15 Intarcia Therapeutics, Inc. Suspension formulation comprising an insulinotropic peptide
EP1726299A3 (de) 2005-05-27 2007-04-18 StratoSphere Pharma AB Kerne und Mikrokapsel zur parenteralen Verabreichung sowie Verfahren zu deren Herstellung
US8017152B2 (en) * 2005-05-27 2011-09-13 Stratosphere Pharma Ab Cores and microcapsules suitable for parenteral administration as well as process for their manufacture
CN101299993A (zh) * 2005-11-04 2008-11-05 伊士曼化工公司 用于给药难溶的药学活性剂的羧烷基纤维素酯
US20080069891A1 (en) 2006-09-15 2008-03-20 Cima Labs, Inc. Abuse resistant drug formulation
US20080075777A1 (en) * 2006-07-31 2008-03-27 Kennedy Michael T Apparatus and methods for preparing solid particles
EP2359808B1 (de) 2006-08-09 2013-05-22 Intarcia Therapeutics, Inc Osmotisches Verabreichungssystem mit Kolbenanordnung
US8445018B2 (en) 2006-09-15 2013-05-21 Cima Labs Inc. Abuse resistant drug formulation
GB0707612D0 (en) 2007-04-19 2007-05-30 Stratosphere Pharma Ab Cores and microcapsules suitable for parenteral administration as well as process for their manufacture
WO2008133908A2 (en) 2007-04-23 2008-11-06 Intarcia Therapeutics, Inc. Suspension formulations of insulinotropic peptides and uses thereof
CA2726861C (en) 2008-02-13 2014-05-27 Intarcia Therapeutics, Inc. Devices, formulations, and methods for delivery of multiple beneficial agents
US20100189845A1 (en) * 2009-01-27 2010-07-29 Frito-Lay North America Inc. Flavor Encapsulation and Method Thereof
US9504274B2 (en) 2009-01-27 2016-11-29 Frito-Lay North America, Inc. Methods of flavor encapsulation and matrix-assisted concentration of aqueous foods and products produced therefrom
RU2547990C2 (ru) 2009-09-28 2015-04-10 Интарсия Терапьютикс, Инк. Быстрое достижение и/или прекращение существенной стабильной доставки лекарственного средства
CA2798702A1 (en) 2010-05-11 2011-11-17 Cima Labs Inc. Alcoholresistant metoprolol-containing extended-release oral dosage forms
US20120208755A1 (en) 2011-02-16 2012-08-16 Intarcia Therapeutics, Inc. Compositions, Devices and Methods of Use Thereof for the Treatment of Cancers
US20150118300A1 (en) 2013-10-31 2015-04-30 Cima Labs Inc. Immediate Release Abuse-Deterrent Granulated Dosage Forms
US9889085B1 (en) 2014-09-30 2018-02-13 Intarcia Therapeutics, Inc. Therapeutic methods for the treatment of diabetes and related conditions for patients with high baseline HbA1c
RU2730996C2 (ru) 2015-06-03 2020-08-26 Интарсия Терапьютикс, Инк. Системы установки и извлечения имплантата
KR102574993B1 (ko) 2016-05-16 2023-09-06 인타르시아 세라퓨틱스 인코포레이티드 글루카곤-수용체 선택적 폴리펩티드 및 이들의 이용 방법
USD860451S1 (en) 2016-06-02 2019-09-17 Intarcia Therapeutics, Inc. Implant removal tool
USD840030S1 (en) 2016-06-02 2019-02-05 Intarcia Therapeutics, Inc. Implant placement guide
JP7286542B2 (ja) 2017-01-03 2023-06-05 インターシア セラピューティクス，インコーポレイティド Ｇｌｐ－１受容体アゴニストの持続的投与及び薬物の同時投与を含む方法
JP2019131511A (ja) * 2018-01-31 2019-08-08 理研ビタミン株式会社 薬物含有粒子の製造方法
US12589083B2 (en) 2019-05-07 2026-03-31 Clexio Biosciences Ltd. Abuse-deterrent dosage forms containing esketamine
US11324707B2 (en) 2019-05-07 2022-05-10 Clexio Biosciences Ltd. Abuse-deterrent dosage forms containing esketamine

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS4845950A (de) * 1971-10-13 1973-06-30
GB1403584A (en) * 1972-05-19 1975-08-28 Beecham Group Ltd Control medicaments
DK152744C (da) * 1982-08-13 1988-10-31 Benzon As Alfred Fremgangsmaade til fremstilling af et farmaceutisk peroralt polydepotpraeparat
JPS61218516A (ja) * 1985-03-25 1986-09-29 Ichimaru Fuarukosu Kk 徐放性マイクロカプセルの製造法
ES2062530T3 (es) * 1989-05-01 1994-12-16 Alkermes Inc Procedimiento para producir particulas pequeñas de moleculas biologicamente activas.
US5017383A (en) * 1989-08-22 1991-05-21 Taisho Pharmaceutical Co., Ltd. Method of producing fine coated pharmaceutical preparation
US5102983A (en) * 1990-04-02 1992-04-07 United States Surgical Corporation Process for preparing foamed, bioabsorbable polymer particles
FR2702968B1 (fr) * 1993-03-23 1995-06-23 Lafon Labor Procédé de préparation de particules renfermant un ingrédient actif par extrusion et lyophilisation .
EP0742888B1 (de) * 1994-02-09 1998-04-22 Kinerton Limited Verfahren zur trocknung eines materials aus einer lösung
WO1997007788A2 (en) * 1995-08-31 1997-03-06 Alkermes Controlled Therapeutics, Inc. Composition for sustained release of an agent
US6113947A (en) * 1997-06-13 2000-09-05 Genentech, Inc. Controlled release microencapsulated NGF formulation
GB2329124B (en) 1997-09-12 2002-05-08 Hiran Asoka Malinga Ratwatte Method of forming dose units of active agents

Also Published As

Publication number Publication date
WO2001019345A1 (en) 2001-03-22
CA2382005A1 (en) 2001-03-22
JP2003509361A (ja) 2003-03-11
DE60003933D1 (de) 2003-08-21
NZ517525A (en) 2003-08-29
DK1214058T3 (da) 2003-11-03
EP1214058A1 (de) 2002-06-19
EP1214058B1 (de) 2003-07-16
ATE245022T1 (de) 2003-08-15
US6753014B1 (en) 2004-06-22
ES2200933T3 (es) 2004-03-16
AU775458B2 (en) 2004-08-05
DE60003933T2 (de) 2004-06-03
US20040219222A1 (en) 2004-11-04
AU7463700A (en) 2001-04-17

Similar Documents

Publication Publication Date Title
SE9903236D0 (sv) Method to obtain microparticles
DE60022664D1 (de) Herstellungsverfahren von submikrometerwirkstoffpartikeln
SE0100823D0 (sv) Method I to obtain microparticles
BR0214279A (pt) Composições farmacêuticas em forma particulada
WO2001015734A3 (en) High viscosity liquid controlled delivery system and medical or surgical device
DE69023682D1 (de) Gefriergetrocknete Polymerdispersionen und ihre Anwendung zur Darstellung von Arzneimittelzubereitungen mit protrahierter Wirkstoffabgabe.
FR2753639B1 (fr) Procede de preparation de microcapsules de matieres actives enrobees par un polymere et nouvelles microcapsules notamment obtenues selon le procede
ATE322919T1 (de) Vorrichtung zur aufbereitung einer medizinischen flüssigkeit
AR017752A1 (es) Composicion de matriz solida y porosa, metodo para su preparacion y metodo para la liberacion controlada de un agente terapeutico utilizando dichamatriz
DK0432232T3 (da) Fremgangsmåde til fremstilling af små partikler af biologisk aktive molekyler
WO2004058218A3 (en) Prefilming atomizer
AR029667A1 (es) Microesfera de liberacion prolongada para administracion inyectable y procedimiento de preparacion
ATE556788T1 (de) Herstellung pharmazeutischer wirkstoffpartikel unter verwendung fokussierter akustischer energie
ATE292393T1 (de) Einkapselung von aktivsubstanzen
MXPA04002446A (es) Preparacion de nanoparticulas de tamano de submicras mediante dispersion y remocion de la fase liquida o solvente.
WO2002018572A3 (en) Membrane penetrating peptides and uses thereof
PL353738A1 (en) Composition containing an active substance, production and use thereof
MXPA04011990A (es) Composiciones farmaceuticas estabilizadas en la base de aceite de ricino polioxietilado y metodo para fabricar el mismo.
CN106236605A (zh) 多孔微球及其制备方法、应用
MY142014A (en) A lipase powder, methods for producing the same and use thereof
BR0115572A (pt) Processos e aparelho para o resfriamento de filamentos em um processo de formação de filamentos
ATE230251T1 (de) Lipidmembran zusammensetzungen
KR970703775A (ko) 혈소판 활동 인자 리셉터를 수반하는 세포질 표적들에 대한 폐렴 구균 점착의 조절체들 및 그들의 이용법(modulators of pneumococcal adhesion to cellular targets involving the platelet activating factor receptor, and uses thereof)
DE60327310D1 (de) Flüssige trägerformulierungen mit hohem wassergehalt
HK1047122A1 (zh) 快速分解的殼聚糖基小丸